NeurologyLive Friday 5 — April 2, 2021

April 2, 2021
NeurologyLive Staff

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending April 2, 2021.

Welcome to NeurologyLive's Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive's widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: Insights: An Overview of Etiology and Prevalence of Pediatric MS

In this Insights series, "Diagnosis and Management of Multiple Sclerosis in Pediatric Patients" Tanuja Chitnis, MD provides an overview of genetic, environmental, and hormonal risk factors for pediatric multiple sclerosis and discusses its prevalence based on age, sex, and geographic location.

2: NeuroVoices: Ralph Sacco, MD, MS, on Florida Stroke Registry, Advancing Stroke Knowledge

The chair of neurology and Olemberg Family Chair of Neurological Disorders at the University of Miami Miller School of Medicine discussed the abundance of research from the Florida Stroke Registry presented at ISC 2021.

3: Cure Connections: Patient Insight: Migraine Triggers

In this Cure Connections series, "The Migraine Patient Journey: Episodic Migraine and CGRP Inhibitors," Philippa Cheetham, MD, and Jill Dehlin, RN, describe what types of triggers seem to be associated with their migraine attacks and explain what they do to try to prevent or reduce the severity of migraines.

4: To Treat or Not to Treat: Secondary Progressive and Primary Progressive MS

Progressive forms of multiple sclerosis present a number of challenges for MS specialists, the biggest of which being whether or not disease-modifying therapy is required.

5: Clarifying Sleep Airflow Obstruction: William Noah, MD

The director and founder of the Sleep Centers of Middle Tennessee discussed the misleading nature of the term ‘sleep apnea' and pharmacological treatment for the condition that is currently being evaluated in phase 2 studies.